ULLAND INVESTMENT ADVISORS, LLC EyePoint Pharmaceuticals, Inc. Transaction History

ULLAND INVESTMENT ADVISORS, LLC portfolio value:

$4,000
portfolio value

ULLAND INVESTMENT ADVISORS, LLC quarter portfolio value change:

+0.51%
quarter

EyePoint Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 0 $7.91 500
Q2 2022 share 0.00% 0 shares -2K $7.87 500
Q1 2022 share 0.00% 0 shares 0 $12.15 500
Q4 2021 share Increase 0.00% 500 shares 6K $12.72 500